THC Farmaceuticals, Inc. engages in the research and development of cannabis pharmaceutical products. The company is headquartered in Scottsdale, Arizona and currently employs 2 full-time employees. The company went IPO on 2012-08-22. The firm specializes in the discovery, development, and commercialization of novel cannabinoid-based products in dental, ophthalmology and other medical disciplines. The company offers the combination of its proprietary developments with its clinicians and scientists to unlock the therapeutic properties of cannabis and its bioactive compounds. The firm owns clinical research center and cannabidiol (CBD) manufacturing facility in California. Its business plan includes conducting cannabinoids research and development in collaboration with cannabis research centers worldwide with the goal of developing novel and advanced therapeutic methods for the treatment of common medical conditions with cannabis-based therapies and to conduct pre-clinical investigations and randomized, placebo-controlled trials of CBD-based compounds and develop condition-specific medications. The company offers a network of micro vending kiosk systems.
Follow-Up Questions
¿Cuál es el ratio P/E de THC Farmaceuticals Inc (CBDG)?
El ratio P/E de THC Farmaceuticals Inc es 0.9768
¿Qué tal es el rendimiento del precio de la acción CBDG?
El precio actual de CBDG es de $0.008, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de THC Farmaceuticals Inc?
THC Farmaceuticals Inc pertenece a la industria Commercial Services & Supplies y el sector es Industrials
¿Cuál es la capitalización bursátil de THC Farmaceuticals Inc?
La capitalización bursátil actual de THC Farmaceuticals Inc es $145.0K
